Lv4
500 积分 2023-12-30 加入
Trastuzumab related cardiotoxicity in nonmetastatic breast cancer: A real-world scenario
6天前
已关闭
Protective strategies to prevent trastuzumab-induced cardiotoxicity
6天前
已完结
The evolving therapeutic landscape of trastuzumab-drug conjugates: Future perspectives beyond HER2-positive breast cancer
6天前
已完结
Targeting undruggable phosphatase overcomes trastuzumab resistance by inhibiting multi-oncogenic kinases
6天前
已完结
Efficacy and safety of trastuzumab with or without a tyrosine kinase inhibitor for HER2-positive breast cancer: A systematic review and meta-analysis
7天前
已完结
Targeting Breast Cancer Using 177Lu-Labeled Trastuzumab and Trastuzumab Fragment
7天前
已完结
752 Novel, orally administered HPK1 inhibitors demonstrate anti-tumor efficacy and enhanced immune response
15天前
已关闭
752 Novel, orally administered HPK1 inhibitors demonstrate anti-tumor efficacy and enhanced immune response
15天前
已关闭
Novel Dual Inhibitor of LSD1-HDAC6/8 for Treatment of Cancer
15天前
已关闭
Novel Dual Inhibitor of LSD1-HDAC6/8 for Treatment of Cancer
15天前
已关闭
皖公网安备34019202002308
